William Lee (L) and Flavius Martin (Gilead, Amgen via YouTube)

Gilead R&D chief William Lee to re­tire as Am­gen I/O vet Flav­ius Mar­tin takes the reins in April

Long­time Gilead R&D chief William Lee is hang­ing up his cleats as the big biotech brings in a new face.

Lee will re­tire in just over a cou­ple weeks on April 12, Gilead an­nounced Fri­day morn­ing. His re­place­ment will be Flav­ius Mar­tin, com­ing over from Am­gen where he led re­search for their on­col­o­gy, in­flam­ma­tion and car­diometa­bol­ic de­part­ments. Mar­tin was al­so the site head for Am­gen South San Fran­cis­co.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.